Prnewswire
Search documents
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
Prnewswire· 2026-02-24 21:05
PharmaceuticalsJazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and developmen ...
Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results
Prnewswire· 2026-02-24 21:05
*Non-GAAP measure; refer to "Non-GAAP Financial Measures" further below for explanatory notes and a reconciliation to the most directly comparable GAAP measure. MESA, Ariz., Feb. 24, 2026 /PRNewswire/ -- Verra Mobility Corporation (NASDAQ: VRRM), a leading provider of smart mobility technology solutions, announced today the financial results for the fourth quarter and full year ended December 31, 2025. "We closed 2025 with strong execution and momentum across our three business segments," said David Roberts ...
Lucid Announces Fourth Quarter and Full Year 2025 Financial Results
Prnewswire· 2026-02-24 21:05
Financial Highlights Operational Highlights Lucid Gravity and Lucid Air Lucid reported fourth quarter revenue of $522.7 million and annual revenue of $1,353.8 million, ending the quarter with approximately $4.6 billion in total liquidity. "2025 was all about execution and strategy adjustment to set Lucid up for long-term success. Against a challenging macro backdrop, we nearly doubled production, gained market share, reduced unit costs, and strengthened our financial position," said Marc Winterhoff, Interim ...
Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call
Prnewswire· 2026-02-24 21:05
Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call[Accessibility Statement] [Skip Navigation]SAN FRANCISCO, Feb. 24, 2026 /PRNewswire/ -- Docusign (Nasdaq: [DOCU]) today announced that its fourth quarter fiscal 2026 results will be released on Tuesday, March 17, 2026, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time) to discuss its financial results. A live webcast of the event will be ava ...
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
Prnewswire· 2026-02-24 21:02
MENLO PARK, Calif., Feb. 24, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 46th Annual Health Care Conference in Boston on Tuesday, Mar. 3 at 10:30 a.m. ET. Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after ...
AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
Prnewswire· 2026-02-24 21:01
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen THOUSAND OAKS, Calif., Feb. 24, 2026 /PRNewswir ...
Axon reports Q4 2025 revenue of $797 million, up 39% year over year
Prnewswire· 2026-02-24 21:01
certain expenses and gains, such as income tax expense and gains or losses on marketable securities and strategic investments. We are unable to reasonably estimate their potential impact, which could be material. Accordingly, we do not provide a reconciliation of projected net income and net income margin to projected Adjusted EBITDA and Adjusted EBITDA margin, respectively.We provide an Adjusted Free Cash Flow target, rather than a cash flow from operating activities target, to provide additional transpare ...
Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
Prnewswire· 2026-02-24 21:01
Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results [Accessibility Statement] Skip NavigationFiscal Fourth Quarter Total Revenues of $2.532 Billion, Up 14.5% Year-Over-YearSubscription Revenues of $2.360 Billion, Up 15.7% Year-Over-YearFiscal Year 2026 Total Revenues of $9.552 Billion, Up 13.1% Year-Over-YearSubscription Revenues of $8.833 Billion, Up 14.5% Year-Over-YearOperating Cash Flows of $2.939 Billion, Up 19.4% Year-Over-YearPLEASANTON, Calif., Feb. 24, 2026 /PRNewswire/ -- ...
Stanley Black & Decker Announces 1st Quarter 2026 Dividend
Prnewswire· 2026-02-24 21:00
Stanley Black & Decker Announces 1st Quarter 2026 Dividend [Accessibility Statement] Skip NavigationNEW BRITAIN, Conn., Feb. 24, 2026 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK), a global leader in tools and outdoor solutions, announced today that its Board of Directors approved a regular first quarter cash dividend of $0.83 per common share. The dividend is payable on Tuesday, March 24, 2026, to shareholders of record as of the close of business on Tuesday, March 10, 2026.About Stanley Black & Decke ...
First Mining Files Final Base Shelf Prospectus and Registration Statement
Prnewswire· 2026-02-24 20:21
performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation:; the potential offering of any Securities by the Company; uncertainty with respect to the completion of any future offering; the ability to obtain applicable regulatory approval for any contemplated offerings; the ability of the Company to negotiate and complete future ...